Ultra Clean Holdings, Inc.
UCTT
$87.29
-4.68%
Ultra Clean Holdings, Inc. is a key supplier to the semiconductor capital equipment industry, manufacturing and supplying critical production tools, modules, and subsystems such as precision robotic solutions, gas delivery systems, and wafer cleaning subsystems. The company operates as a critical enabler within the semiconductor ecosystem, providing essential components that ensure the precision and cleanliness required for advanced chip manufacturing. The current investor narrative centers on the stock's explosive re-rating, driven by a dramatic surge in its share price of over 280% over the past year, which appears to be fueled by a cyclical recovery in semiconductor equipment spending and heightened investor optimism around its role in the AI-driven expansion of chip fabrication capacity. Recent analyst actions, maintaining Buy or Outperform ratings throughout this period, suggest institutional confidence in the company's positioning within this upcycle.…
UCTT
Ultra Clean Holdings, Inc.
$87.29
Investment Opinion: Should I buy UCTT Today?
Rating: Hold. The core thesis is that UCTT is a high-risk, high-beta cyclical play where the anticipated recovery is already heavily priced in, creating an asymmetric risk/reward profile that favors caution until fundamental confirmation emerges. Supporting this Hold rating are several specific data points. First, valuation sends mixed signals: the trailing PS ratio of 0.57 appears cheap, but the forward EV/Sales of 2.13 and forward P/E of 22.8 imply the market expects robust growth and margin improvement. Second, current fundamentals are weak, with revenue declining -10.1% YoY and a net loss reported in the latest quarter. Third, while analyst sentiment is bullish, coverage is limited to just a few firms, and the wide EPS estimate range ($6.23-$7.57) underscores high uncertainty. Finally, the technical picture shows extreme overextension after a 281.6% rally, with the stock trading at 97% of its 52-week high. The rating would upgrade to a Buy on concrete evidence of the cyclical turn, such as two consecutive quarters of sequential revenue growth and gross margin expansion above 18%. It would downgrade to a Sell if revenue growth fails to materialize by late 2026 or if the stock breaks below key technical support around $55 on heavy volume. Relative to its own history, the stock is fairly valued on a sales basis at a PS of 0.57, but relative to the growth expectations embedded in its forward multiples, it appears overvalued given the current lack of profitability.
Sign up to view all
UCTT 12-Month Price Forecast
UCTT is a pure-play bet on the timing and strength of the semiconductor equipment cycle, currently in a precarious state of being 'priced for perfection.' The neutral stance reflects the high probability (50%) of a base case where the stock churns within a wide range as fundamentals slowly catch up to the inflated price. The risk/reward is asymmetric to the downside given the technical overextension and high beta. The stance would upgrade to bullish on confirmation of the revenue inflection and margin expansion, likely requiring two consecutive quarters of positive data. It would downgrade to bearish if the stock breaks below the $55 support level, signaling a failure of the momentum trade.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ultra Clean Holdings, Inc.'s 12-month outlook, with a consensus price target around $113.48 and implied upside of +30.0% versus the current price.
Average Target
$113.48
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$70 - $113
Analyst target range
Analyst coverage for UCTT appears limited, with the provided data indicating only one analyst providing estimates for revenue and EPS. The estimated revenue for the forward period is $4.19 billion, and the estimated EPS is $6.65, with a range from $6.23 to $7.57. This single data point is insufficient to derive a meaningful consensus price target or recommendation distribution. The institutional ratings data shows three firms (TD Cowen, Needham, and Oppenheimer) have maintained Buy or Outperform ratings consistently from early 2025 through February 2026, indicating a bullish institutional sentiment that has persisted through the stock's massive rally. The lack of a broad analyst consensus with price targets implies limited coverage, which is typical for small to mid-cap companies like UCTT with a market cap of approximately $3.5 billion. This limited coverage can lead to higher volatility and less efficient price discovery, as the stock is more susceptible to sentiment shifts among a smaller group of informed investors. The sustained bullish ratings from the few covering analysts, however, provide a signal of confidence in the company's strategic position within the semiconductor equipment supply chain, especially as it relates to the AI-driven capacity build-out. The wide implied EPS range from the single analyst (low of $6.23 to high of $7.57) underscores the high uncertainty and variability in forward estimates, which is characteristic of a company at an inflection point in a cyclical industry.
Bulls vs Bears: UCTT Investment Factors
The bull case for UCTT is powerful but almost entirely anticipatory, built on the expectation of a sharp cyclical recovery in semiconductor equipment spending, particularly for AI-related fabrication. The bear case is grounded in the stark reality of deteriorating current fundamentals, extreme technical overextension, and poor profitability metrics. Currently, the bullish narrative has stronger momentum, as evidenced by the 281.6% price surge and sustained institutional Buy ratings. However, this creates a precarious situation where the stock is priced for near-perfect execution. The single most important tension in the investment debate is the timing and magnitude of the cyclical recovery versus the stock's already elevated price. If the recovery materializes quickly and strongly, the low PS ratio offers significant upside. If it is delayed or disappoints, the combination of high beta, negative earnings, and technical overextension could trigger a severe correction.
Bullish
- Massive Cyclical Re-rating Underway: The stock price has surged 281.6% over the past year, driven by investor anticipation of a recovery in semiconductor equipment spending and its role in AI-driven capacity expansion. This explosive move suggests the market is aggressively pricing in a cyclical inflection point, with the stock trading at 97% of its 52-week high.
- Strong Institutional Sentiment: Analysts from TD Cowen, Needham, and Oppenheimer have maintained Buy or Outperform ratings consistently from early 2025 through February 2026, indicating sustained institutional confidence despite the stock's massive rally. This bullish sentiment from the limited covering analysts supports the narrative of a strategic position within the semiconductor supply chain.
- Low Valuation on Sales Basis: The trailing Price-to-Sales (PS) ratio of 0.57 is near the bottom of its historical range, which has seen PS ratios as high as 5.53. This suggests the stock is being valued near cyclical lows, potentially offering significant multiple expansion if the anticipated recovery in revenue and margins materializes.
- Positive Free Cash Flow Generation: Despite reporting net losses, the company generated positive free cash flow of $14.7 million over the trailing twelve months. This demonstrates the core business can produce cash from operations, providing financial flexibility and reducing liquidity risk during the cyclical downturn.
Bearish
- Fundamental Deterioration Amid Rally: The stock's 281.6% rally contrasts sharply with deteriorating fundamentals: Q4 2025 revenue declined 10.1% YoY to $506.7M, and the company reported a net loss of -$3.3M. The trailing net margin is -8.8%, highlighting a disconnect between price action and current financial performance.
- Extreme Technical Overextension: Trading at $85.94, the stock is positioned 97% of the way from its 52-week low ($18.93) to its high ($88.37), indicating extreme momentum and leaving little room for disappointment. The high beta of 1.94 confirms nearly double the market's volatility, making it susceptible to sharp corrections on any negative news.
- Persistent Profitability Challenges: Profitability metrics are deeply concerning: Return on Equity is -25.5%, Return on Assets is a minimal 1.4%, and gross margin for Q4 2025 was only 15.3%. These figures indicate significant inefficiency and pricing pressure, raising questions about the company's ability to capitalize on a recovery.
- Moderate Financial Leverage: A debt-to-equity ratio of 1.14 indicates the company carries more debt than equity, adding financial risk and interest expense pressure during a downturn. This leverage could amplify losses if the anticipated cyclical recovery is delayed or weaker than expected.
UCTT Technical Analysis
The stock is in a powerful, sustained uptrend, with a staggering 281.6% price increase over the past year. As of the latest close at $85.94, the price is trading near the top of its 52-week range, approximately 97% of the way from its 52-week low of $18.93 toward its high of $88.37, indicating extreme momentum and potential overextension. This positioning suggests the stock is priced for near-perfect execution, leaving little room for disappointment, and is susceptible to sharp corrections on any negative news. Short-term momentum remains strongly positive but shows signs of volatility; the stock is up 13.0% over the past month and 55.2% over the past three months, though these gains are a deceleration from the explosive 6-month return of 259.6%. The 1-month relative strength of 7.36% against the SPY indicates the stock continues to outperform the broader market, albeit with significant daily swings as evidenced by the high beta of 1.94, meaning it is approximately 94% more volatile than the market. Key technical support is anchored at the 52-week low of $18.93, though given the massive rally, more relevant near-term support likely resides around the $55-$60 level where the stock consolidated in March. Immediate resistance is the recent 52-week high of $88.37; a decisive breakout above this level could signal a continuation of the bull run, while a failure could trigger a significant pullback as momentum wanes. The stock's beta of 1.94 confirms its high-risk, high-reward profile, being nearly twice as volatile as the SPY, which necessitates careful position sizing for risk management. The elevated short interest, with a short ratio of 2.39, indicates a notable bearish contingent that could fuel further volatility, potentially exacerbating moves in either direction.
Beta
1.94
1.94x market volatility
Max Drawdown
-29.7%
Largest decline past year
52-Week Range
$19-$92
Price range past year
Annual Return
+330.6%
Cumulative gain past year
| Period | UCTT Return | S&P 500 |
|---|---|---|
| 1m | +11.6% | +6.0% |
| 3m | +43.9% | +10.0% |
| 6m | +244.2% | +10.4% |
| 1y | +330.6% | +28.4% |
| ytd | +219.5% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
UCTT Fundamental Analysis
Revenue trends show a company navigating a cyclical downturn, with the most recent quarterly revenue of $506.7 million representing a -10.1% year-over-year decline. Sequentially, revenue has declined from $518.6M in Q1 2025 to $506.7M in Q4 2025, indicating persistent top-line pressure. The business is segmented into Products ($442.4M) and Services ($64.2M), with the Product segment constituting the vast majority of sales. The declining revenue trajectory reflects the broader semiconductor equipment slowdown but sets a lower base for a potential cyclical recovery, which the market appears to be aggressively pricing in. Profitability remains challenged, with the company reporting a net loss of -$3.3 million in Q4 2025 and a trailing twelve-month net margin of -8.8%. Gross margin for the quarter was 15.3%, which is low for the technology sector and reflects pricing pressure and mix issues. However, operating income was positive at $10.9 million, yielding a slim operating margin of 2.1%, suggesting the core business can be marginally profitable at this revenue level before interest and taxes. The significant net loss in Q2 2025 (-$162M) due to a $151.1M 'other expense' skews the annual picture, but the trend in recent quarters shows the company struggling to achieve consistent bottom-line profitability. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.14, indicating more debt than equity, which adds financial risk in a cyclical downturn. Liquidity is strong with a current ratio of 3.19, providing ample short-term coverage. Free cash flow over the trailing twelve months is positive at $14.7 million, a crucial metric showing the company can generate cash from operations despite net losses. Return on Equity is deeply negative at -25.5%, and Return on Assets is a minimal 1.4%, highlighting significant inefficiency in generating profits from its asset base. The financial health is adequate for survival but not robust, heavily reliant on a market recovery to improve returns.
Quarterly Revenue
$506700000.0B
2025-12
Revenue YoY Growth
-0.10%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$14700000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is UCTT Overvalued?
Given the company's negative trailing net income and negative EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 0.57, which appears inexpensive on the surface, especially when compared to the forward-looking EV/Sales multiple of 2.13, suggesting the market expects significant sales growth and/or margin improvement to justify a higher enterprise value. The gap between the simple PS and the EV/Sales indicates the market is incorporating the company's debt load into its valuation, making the enterprise value multiple more relevant. Compared to industry averages, specific data is not provided in the valuation data set, but a PS ratio of 0.57 is generally low for a semiconductor capital equipment company, even one with cyclicality. This suggests the stock may be trading at a discount to the sector on a sales basis. However, this discount is likely warranted given its negative profitability, compressed gross margins of 15.7%, and high financial leverage. The valuation premium/discount is intrinsically tied to the market's belief in a sharp cyclical recovery; if growth and margins materialize, the current multiples could expand significantly. Historically, the stock's own valuation provides critical context. The current PS ratio of 0.57 is near the bottom of its historical range observed in the provided data, which has seen PS ratios as high as 5.53 in early 2021. This suggests the stock is being valued near cyclical lows based on sales, which could represent a value opportunity if the semiconductor equipment cycle is indeed turning. However, it also reflects the market's skepticism after a period of fundamental deterioration, pricing the stock for a scenario where a robust recovery is not guaranteed.
PE
-6.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -196x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-53.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are elevated. The company is currently unprofitable with a trailing net margin of -8.8% and a gross margin of just 15.7%, indicating severe pricing pressure and mix issues in its product segment, which constitutes 87% of revenue. While free cash flow is positive at $14.7M TTM, the debt-to-equity ratio of 1.14 adds financial leverage risk, meaning interest expenses could pressure margins further if rates remain high. The company's return metrics are alarming, with a -25.5% ROE, suggesting shareholder capital is being destroyed at the current level of operations. Revenue concentration in the cyclical semiconductor equipment industry means earnings visibility is low, and the recent -10.1% YoY revenue decline confirms the downturn is ongoing. Market & Competitive Risks are significant. The stock's 281.6% rally has pushed it to the top of its 52-week range, creating substantial valuation compression risk if the growth narrative falters. With a beta of 1.94, the stock is 94% more volatile than the market, making it highly sensitive to broader market downturns or sector rotation out of cyclical names. Competitive risks are inherent as a supplier in the semiconductor capital equipment industry, where customers may dual-source or in-source critical components. The elevated short interest, with a short ratio of 2.39, indicates a notable bearish contingent that could fuel increased volatility and downward pressure if the recovery thesis shows cracks. Worst-Case Scenario involves a delayed or failed semiconductor equipment recovery coupled with a broader market correction. In this adverse scenario, revenue continues to decline sequentially, gross margins fail to improve from the ~15% level, and net losses widen. The high beta would amplify the downside, potentially triggering a rush for exits among momentum investors and covering by short sellers. A realistic downside could see the stock retrace a significant portion of its gains, testing the $55-$60 consolidation level (a -30% to -35% decline from $85.94) and, in a severe downturn, potentially revisiting its 52-week low of $18.93, representing a catastrophic -78% loss. The most probable severe downside in the next 12 months, however, is a -35% to -40% correction to the $50-$55 range if earnings disappoint.
FAQ
The key risks are, in order of severity: 1) Cyclical Timing Risk: The stock's 281.6% rally assumes a recovery is imminent. If the semiconductor equipment upcycle is delayed or weaker than expected, the stock could crash. 2) Financial Risk: The company is currently unprofitable (net margin -8.8%) and carries moderate debt (D/E of 1.14), making it vulnerable if the downturn persists. 3) Volatility Risk: With a beta of 1.94, the stock is nearly twice as volatile as the market, leading to large, unpredictable swings. 4) Execution Risk: Even in a recovery, the company must improve its low 15.3% gross margin to generate meaningful profits, which is not guaranteed.
The 12-month forecast is highly bifurcated, with a base case target range of $70-$90 (50% probability), a bull case of $105-$125 (25% probability), and a bear case of $40-$60 (25% probability). The most likely scenario is the base case, where a moderate recovery leads to consolidation at elevated levels. This forecast hinges on the critical assumption that semiconductor equipment spending begins a gradual recovery in late 2026 or early 2027. The wide range of outcomes reflects the stock's high beta, cyclical nature, and the current disconnect between its price and fundamentals.
UCTT's valuation presents a paradox. On a trailing sales basis, it appears undervalued with a Price-to-Sales ratio of 0.57, which is near the bottom of its historical range. However, the forward-looking Enterprise Value-to-Sales multiple of 2.13 and a forward P/E of 22.8 imply the market is already pricing in significant sales growth and a return to profitability. Compared to its current weak fundamentals (-8.8% net margin), the stock is overvalued. The valuation implies the market expects a sharp V-shaped recovery in both top-line growth and margins. If those expectations are met, the stock could be fairly valued or even cheap; if they are missed, it is significantly overvalued.
UCTT is a high-risk, high-potential reward stock that is not a good buy for most investors at current levels. After a 281.6% rally, the stock is priced for a near-perfect semiconductor equipment recovery, yet current fundamentals show a -10.1% revenue decline and net losses. For aggressive, tactical investors with a high risk tolerance and a strong conviction that the cycle is turning imminently, it could represent a leveraged bet. However, the high beta of 1.94 and technical overextension mean the downside risk is substantial. A more prudent approach would be to wait for concrete fundamental improvement, such as a return to revenue growth, before considering a position.
UCTT is unsuitable for short-term trading for all but the most experienced and risk-aware traders due to its extreme volatility (beta 1.94). It does not pay a dividend, eliminating an income component. For a long-term investor, it could serve as a speculative, cyclical holding within a diversified portfolio, but the investment horizon must align with the multi-year semiconductor equipment cycle, suggesting a minimum holding period of 2-3 years to ride through the volatility and capture the full potential of the upcycle. Given its current stage—anticipating a recovery but not yet demonstrating it—it is primarily a tactical, theme-driven investment rather than a core long-term holding.